
Blackrock Neurotech Stock
Blackrock Neurotech specializes in developing advanced brain-computer interface (BCI) technology that helps individuals with neurological conditions, including paralysis, regain independence. Their devices allow patients to interact with digital systems or control robotic limbs using only their thoughts. The company's innovation empowers users to perform everyday activities and access new forms of communication, offering life-changing possibilities for those with motor impairments.
Sign up for SecondMarket™ to view the market and buy or sell Blackrock Neurotech Stock
Buy + SellSee Blackrock Neurotech Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Blackrock Neurotech Stock Valuation + Share Prices
View real-time Tape D™ data on Blackrock Neurotech stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedBlackrock Neurotech Management Team
Director, Co-Founder, Chief Science Officer
Florian Solzbacher
Director
Tim Sievers
Director, Co-Founder, CEO
Marcus C. Gerhardt
CFO
Thomas Thiele
Director
Max de Vere
Director
Christian Angermayer
Blackrock Neurotech Major Investors
Sorenson Impact Group
re.Mind Capital
Tether
Learn More About Blackrock Neurotech Stock
Buy Blackrock Neurotech Stock
01Blackrock Neurotech stock does not trade on public stock exchanges. Blackrock Neurotech stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Blackrock Neurotech stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Blackrock Neurotech Stock
02Blackrock Neurotech Stock does not trade on public stock exchanges. In order to sell Blackrock Neurotech shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Blackrock Neurotech Stock Price
03Blackrock Neurotech does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Blackrock Neurotech share price and other valuable private market data.
Read more about secondary market private company stock prices:
Blackrock Neurotech Stock Ticker Symbol
04There is no ticker symbol for Blackrock Neurotech stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Blackrock Neurotech Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Blackrock Neurotech stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Blackrock Neurotech Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Blackrock Neurotech stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Blackrock Neurotech Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Blackrock Neurotech IPO
08Blackrock Neurotech is a private company and has not had an IPO. There is currently no Blackrock Neurotech IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Blackrock Neurotech IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Blackrock Neurotech Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.